KLRK1 and cancer: Further studies reported that TEVs derived from diverse cancer cell lines, including mesothelioma, breast and prostate cancer cells, express NKG2DL and thereby down-regulate NKG2D expression on NK cells and CD8+ T cells, resulting in impaired cytotoxic effector functions [85,86].